NervGen Pharma

NervGen Pharma

Canada
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases. The company's lead compound, NVG-291, has placed ahead for both spinal cord injury and multiple sclerosis. The company plans to initiate a Phase 1 human clinical trial on healthy subjects in early 2020 with an expansion of the trial in the second half of 2020 to include a cohort of spinal cord injury patients. In addition, the company intends to commence a Phase 2 multiple sclerosis clinical trial in early 2021.
Founded date
01/01/2017
# of employees
11-50
Company type
For Profit

General & financials

Estimated revenue
$1M to $10M
# of funders
3
Founders
Brian McAlister, Harold Martin Punnett, William Joseph Radvak
Industry group
Biotechnology, Health Care, Science and Engineering

Founding

Top 5 investors
U.S. Department of Defense, CSBio, PFP Biosciences
# of funding runds
7
Last founding
$1.500.000
Total funded
$34.053.525

See more companies

See full list
ZyVersa Therapeutics

ZyVersa Therapeutics

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
AbilTo

AbilTo

Estimated revenue
$1M to $10M
# of employees
101-250
Company type
For Profit
Eureka93

Eureka93

Estimated revenue
$1M to $10M
# of employees
51-100
Company type
For Profit
Axio Biosolutions

Axio Biosolutions

Estimated revenue
$10M to $50M
# of employees
101-250
Company type
For Profit
Droplette

Droplette

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
3Scan

3Scan

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
ICAgen

ICAgen

Estimated revenue
$10M to $50M
# of employees
11-50
Company type
For Profit
Rx Savings Solutions

Rx Savings Solutions

Estimated revenue
$1M to $10M
# of employees
251-500
Company type
For Profit

How to get access to the full list?

Duplicate this list

Get access to a comprehensive list of companies with their industries, location and contacts infos.

Prepare outreach

Drafting good emails makes you more likely to get get results.

Track & Follow

Keeping momentum by managing all your angel investors prospects in a pipeline with pre-set stages: "contacted", "replied", "in discussion" for ex. Follow-up tightly, close in time.

What is folk?

folk is a lightweight and easy-to-use CRM that you can leverage to build lists of contacts and manage your processes with these contacts.

How to get access to this list of companies?

You can simply duplicate the list. You will need to create a folk account in order to duplicate the list properly.

What can I do with the list after duplicating it? 

On folk, you can directly email these companies and manage them in a pipeline board.